Previous Article | Next Article ![]()
Mol. Cell. Biol., Dec 1997, 7398-7406, Vol 17, No. 12
JN Davis, CO Rock, M Cheng, JB Watson, RA Ashmun, H Kirk, RJ Kay and MF Roussel
Substitution of phenylalanine for tyrosine at codon 809 (Y809F) of the
human colony-stimulating factor 1 (CSF-1) receptor (CSF-1R) impairs
ligand-stimulated tyrosine kinase activity, prevents induction of c-MYC and
cyclin D1 genes, and blocks CSF-1-dependent progression through the G1
phase of the cell cycle. We devised an unbiased genetic screen to isolate
genes that restore the ability of CSF-1 to stimulate growth in cells that
express mutant CSF-1R (Y809F). This screen led us to identify a truncated
form of the murine type Ibeta phosphatidylinositol 4-phosphate 5-kinase
(mPIP5K-Ibeta). This truncated protein lacks residues 1 to 238 of
mPIP5K-Ibeta and is catalytically inactive. When we transfected cells
expressing CSF-1R (Y809F) with mPIP5K-Ibeta (delta1-238), CSF-1-dependent
induction of c-MYC and cyclin D1 was restored and ligand-dependent cell
proliferation was sustained. CSF-1 normally triggers the rapid
disappearance of CSF-1R (Y809F) from the cell surface; however,
transfection of cells with mPIP5K-Ibeta (delta1- 238) stabilized CSF-1R
(Y809F) expression on the cell surface, resulting in elevated levels of
ligand-activated CSF-1R (Y809F). These results suggest a role for
PIP5K-Ibeta in receptor endocytosis and that the truncated enzyme
compensated for a mitogenically defective CSF-1R by interfering with this
process.
Copyright © 1997, American Society for Microbiology
Complementation of growth factor receptor-dependent mitogenic signaling by a truncated type I phosphatidylinositol 4-phosphate 5-kinase
Department of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»